These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7164412)

  • 1. [Fibrin fibrinogen degradation products in the urine and blood in patients with diabetes mellitus and renal complications].
    Astrug A; Shipkova P
    Vutr Boles; 1982; 21(5):81-8. PubMed ID: 7164412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fibrin degradation products in the urine in diabetic nephropathy].
    Khristov V; Apostolov P; Stamenova T
    Vutr Boles; 1979; 18(4):32-6. PubMed ID: 494630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood serum and urine levels of fibrin fibrinogen degradation products in kidney diseases].
    Kacprzyk F; Orłowski Z
    Pol Tyg Lek; 1980 Mar; 35(13):461-3. PubMed ID: 7393746
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary-plasmin alpha 2 plasmin inhibitor complex (PIC) in patients with diabetic nephropathy].
    Saigo K; Ryo R; Yamaguchi N
    Rinsho Byori; 1993 Jul; 41(7):785-8. PubMed ID: 8361049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy.
    Poirier LA; Brown AT; Fink LM; Wise CK; Randolph CJ; Delongchamp RR; Fonseca VA
    Metabolism; 2001 Sep; 50(9):1014-8. PubMed ID: 11555831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen degradation products in acute renal failure of the newborn.
    Assadi F; Delivoria-Papadopoulos M; Pereira G; Peckham G; Norman M
    Clin Nephrol; 1983 Feb; 19(2):74-81. PubMed ID: 6839555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases].
    Shibata T; Magari Y; Mizunaga S; Okabe E; Sumie A; Ishii T; Tomo T; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):805-12. PubMed ID: 8072218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
    Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
    Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary cross-linked FDP in various renal diseases].
    Inuma H
    Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):146-57. PubMed ID: 8139147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
    Bendel M; Oetliker O; Montandon A; Beck EA
    Schweiz Med Wochenschr; 1975 Aug; 105(33):1040-7. PubMed ID: 1099647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
    Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP
    Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary fibrin degradation products in childhood acute nephritis.
    Dawson KP
    N Z Med J; 1977 Oct; 86(597):332-4. PubMed ID: 272538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal vein fibrin degradation products (FDP's) in glomerulonephritis.
    Tomura S; Ideura T; Ida T; Osaka Y; Kuriyama R; Abe T; Takeuchi J
    Clin Nephrol; 1979 Dec; 12(6):248-53. PubMed ID: 527278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrinogen degradatiopnroducts in the serum and urine in chronic nephritis].
    Kutyrina IM; Muzychenko LI; Nevraeva OG; Kriachko AA; Tareeva IE
    Sov Med; 1978 Oct; (10):68-75. PubMed ID: 715539
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of urinary excretion of fibrin degradation products during treatment of glomerulonephritis.
    Michielsen P; Roels L; Vanrenterghem Y; Boel A; van Damme B; Vermylen J
    Clin Nephrol; 1976 Mar; 5(3):105-13. PubMed ID: 1261101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
    Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
    Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.